HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2019, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2019-02-13
DOI
10.1155/2019/4183157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol
- (2018) Nobukazu Fujimoto et al. Clinical Lung Cancer
- Extracellular HMGB1 as a therapeutic target in inflammatory diseases
- (2018) Ulf Andersson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma
- (2018) Eltjona Rrapaj et al. HISTOPATHOLOGY
- Prognostic significance of combining high mobility group Box-1 and OV-6 expression in hepatocellular carcinoma
- (2018) Jihui Zhu et al. Science China-Life Sciences
- High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
- (2018) Ulf Andersson et al. SEMINARS IN IMMUNOLOGY
- Suppressed epithelial‑mesenchymal transition and cancer stem cell properties mediate the anti‑cancer effects of ethyl pyruvate via regulation of the AKT/nuclear factor‑κB pathway in prostate cancer cells
- (2018) Bin Huang et al. Oncology Letters
- MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma
- (2018) Jianing Yan et al. Biomed Research International
- Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
- (2018) Caterina Ledda et al. Cancers
- Current treatments and trials in malignant pleural mesothelioma
- (2018) Anna C. Bibby et al. Clinical Respiratory Journal
- Scientific Advances and New Frontiers in Mesothelioma Therapeutics
- (2018) Luciano Mutti et al. Journal of Thoracic Oncology
- Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications
- (2018) Fabien Forest et al. PATHOLOGY
- Hand-spinning chrysotile exposure and risk of malignant mesothelioma: A case-control study in Southeastern China
- (2017) Zhaoqiang Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
- (2017) Lauren Elizabeth Walker et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
- (2017) Evan W Alley et al. LANCET ONCOLOGY
- Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
- (2017) Tsai-Tsen Liao et al. Molecular Oncology
- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
- (2017) Charli Dominguez et al. SEMINARS IN CANCER BIOLOGY
- Cancer Inflammation and Cytokines
- (2017) Maria Rosaria Galdiero et al. Cold Spring Harbor Perspectives in Biology
- Expression levels and clinical significance of hepsin and HMGB1 proteins in cervical carcinoma
- (2017) Hui Cheng et al. Oncology Letters
- Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
- (2017) Sabrina Lagniau et al. Oncotarget
- HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
- (2017) Laura Pellegrini et al. Oncotarget
- Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program
- (2017) Selma Metintaş et al. International Journal of Environmental Research and Public Health
- Biomarkers in mesothelioma
- (2017) David T Arnold et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China
- (2017) Weimin Mao et al. JAMA Oncology
- Ethyl Pyruvate Administration Suppresses Growth and Invasion of Gallbladder Cancer Cells via Downregulation of Hmgb1-Rage Axis
- (2017) M-L. Li et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats
- (2017) Dengli Wang et al. Scientific Reports
- Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
- (2016) Davide Capodanno et al. CIRCULATION
- HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
- (2016) A. Napolitano et al. CLINICAL CANCER RESEARCH
- Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
- (2016) Tatsuya Sasaki et al. EXPERIMENTAL NEUROLOGY
- Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries
- (2016) Runkuan Yang et al. Journal of Inflammation-London
- Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)
- (2016) S. Cedrés et al. LUNG CANCER
- High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro
- (2016) Xiaoao Pang et al. ONCOLOGY REPORTS
- The Global Health Dimensions of Asbestos and Asbestos-Related Diseases
- (2016) Ken Takahashi et al. Annals of Global Health
- High-mobility group Box 1: A novel inducer of the epithelial–mesenchymal transition in colorectal carcinoma
- (2015) Lingyin Zhu et al. CANCER LETTERS
- Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice
- (2015) Ralph A. Pietrofesa et al. CARCINOGENESIS
- Bioactivation of Phytoestrogens: Intestinal Bacteria and Health
- (2015) J. M. Landete et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer
- (2015) Hye Won Chung et al. INTERNATIONAL JOURNAL OF CANCER
- Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer
- (2015) Zhengxiang Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Unknown
- (2015) Hyong Choi et al. MOLECULAR MEDICINE
- Potential protective properties of flax lignan secoisolariciresinol diglucoside
- (2015) Muhammad Imran et al. Nutrition Journal
- High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma
- (2015) Yun-Fei Xu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
- (2015) H Yang et al. Cell Death & Disease
- Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies
- (2015) Angela Bononi et al. Expert Review of Respiratory Medicine
- High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
- (2014) Xiaodong Ge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
- (2014) B. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential role of High mobility group box 1 in hepatocellular carcinoma
- (2014) Rong-Rong Zhou et al. Cell Adhesion & Migration
- The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
- (2014) Cem Sezer MEDICAL SCIENCE MONITOR
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Continuous Exposure to Chrysotile Asbestos Can Cause Transformation of Human Mesothelial Cells via HMGB1 and TNF-α Signaling
- (2013) Fang Qi et al. AMERICAN JOURNAL OF PATHOLOGY
- Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1–RAGE and AKT pathways
- (2013) Ping Cheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
- (2013) Chiharu Tabata et al. BMC CANCER
- HMGB1 in Cancer: Good, Bad, or Both?
- (2013) R. Kang et al. CLINICAL CANCER RESEARCH
- The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey
- (2013) Serdar Berk et al. ENVIRONMENTAL GEOCHEMISTRY AND HEALTH
- Serum HMGB1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma
- (2013) Chiharu Tabata et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release
- (2013) He-Xin Yan et al. JOURNAL OF HEPATOLOGY
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
- (2013) Domenica Musumeci et al. PHARMACOLOGY & THERAPEUTICS
- Exploring glyoxalase 1 expression in prostate cancer tissues: Targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties
- (2013) Martin Baunacke et al. PROSTATE
- Regulation of HMGB1 release by inflammasomes
- (2013) Ben Lu et al. Protein & Cell
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
- (2012) S. Jube et al. CANCER RESEARCH
- Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity
- (2012) Daniel J. Antoine et al. JOURNAL OF HEPATOLOGY
- HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
- (2012) Helena Erlandsson Harris et al. Nature Reviews Rheumatology
- Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo
- (2012) Jin-Shui Zhu ONCOLOGY REPORTS
- Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
- (2011) M. Carbone et al. CLINICAL CANCER RESEARCH
- HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
- (2011) José Augusto Nogueira-Machado et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds
- (2010) Kenneth K. Kao et al. BIOCHEMICAL PHARMACOLOGY
- Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation
- (2010) Haining Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Ethyl pyruvate administration inhibits hepatic tumor growth
- (2009) Xiaoyan Liang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
- (2009) Hideyuki Yanai et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started